From: Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients
Group 1 | Group 2 | Group 3 | |||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | VRE+ | VRE - | p value | VRE+ | VRE - | p value | VRE+ | VRE - | p value |
Gender | |||||||||
Male | 10(71.4) | 58(65.9) | 0.769 | 6(54.5) | 35(56.5) | 1 | 4(30.8) | 50(54.3) | 0.111 |
Ages, in years | 43 ± 14 | 39 ± 13 | 0.579 | 40 ± 10 | 41 ± 13 | 0.857 | 41 ± 11 | 42 ± 10 | 0.789 |
Race | |||||||||
White | 11(78.6) | 61(69.3) | 7(63.6) | 41(66.1) | 12(92.3) | 55(59.8) | |||
Non-white | 3(21.4) | 27(30.6) | 0.494 | 7(63.6) | 21(33.9) | 0.791 | 1(7.7) | 37(40.3) | 0.122 |
Primary renal disease | |||||||||
Indeterminate | 8(57.1) | 45(51.1) | 6(54.5) | 32(51.6) | 7(53.8) | 39(42.4) | |||
Hypertension | 3(21.4) | 17(19.3) | 3(27.3) | 16(25.8) | 22(23.9) | ||||
Glomerulonephritis | 3(21.4) | 15(17) | 6(9.7) | 3(23.1) | 17(18.5) | ||||
Diabetes Mellitus | 4(4.5) | 3(4.8) | 1(7.7) | 3(3.3) | |||||
Others | 7(8) | 0.934 | 2(18.2) | 5(8.1) | 0.752 | 2(15.4) | 11(12) | 0.195 | |
Pre transplant treatment | |||||||||
Hemodialysis | 13(92.9) | 79(89.8) | 11(100) | 58(93.5) | 10(76.9) | 91(98.9) | |||
CAPD | 7(8) | 2(3.2) | 2(15.4) | 1(1.1) | |||||
Conservative | 1(7.1) | 2(2.3) | 0.269 | 2(3.2) | 1 | 1(7.7) | 0.006 | ||
Kidney donor | |||||||||
HLA I and II | 6(42.9) | 55(62.5) | 5(45.5) | 36(58.1) | 8(61.5) | 50(54.3) | |||
HLA III and deceased donor | 8(57.1) | 33(37.5) | 0.164 | 6(54.5) | 26(41.9) | 0.518 | 5(38.5) | 42(45.7) | 0.626 |
Surgical reexploration | 1(7.1) | 1(1.1) | 0.257 | 1(9.1) | 5(8.1) | 1 | 2(15.4) | 4(4.3) | 0.16 |
Mycophenolate mofetil | 3(27.3) | 31(50) | 0.164 | 4(30.8) | 21(22.8) | 0.504 | |||
OKT3/Thymoglobulin® | 7(11.3) | 0.585 | 6(6.5) | 1 | |||||
Methylprednisolone pulse | 2(18.2) | 20(32.3) | 0.486 | 4(30.8) | 32(34.8) | 1 | |||
Pos-transplantation dialysis | 4(28.6) | 14(15.9) | 0.265 | 13(21) | 0.195 | 1(7.7) | 14(15.2) | 0.687 | |
Length of hospitalization in days | 7 ± 2 | 8 ± 5 | 0.714 | 18 ± 22 | 17 ± 15 | 0.617 | 31 ± 36 | 23 ± 20 | 0.223 |
Serology | |||||||||
Hepatitis C virus | 1(7.1) | 7(8) | 1 | 1(1.6) | 1 | 4(30.8) | 18(21.4) | 0.462 | |
Hepatitis B virus | 4(4.5) | 1 | 1(1.6) | 1 | 1(7.7) | 1(1.2) | 0.236 | ||
Antimicrobial drugs | 7(63.6) | 31(50) | 0.519 | 10(76.9) | 69(75) | 1 | |||
Vancomycin | 1(9.1) | 1(1.6) | 0.28 | 3(23.1) | 6(6.5) | 0.081 | |||
Ganciclovir | 6(9.7) | 0.582 | 2(15.4) | 10(10.8) | 0.642 |